Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis

Journal of Neurology

Volumn 246, Issue 4, 1999, Pages 292-298

  Bergh, Florian Then ^a   Grasser, Annette ^a   Trenkwalder, Claudia ^a   Backmund, Herbert ^a   Holsboer, Florian ^a   Rupprecht, Rainer ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Dexamethasone CRH test; Glucocorticoid receptors; Lymphocytes; Multiple sclerosis

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DISSOCIATION CONSTANT; FEMALE; HUMAN; HUMAN CELL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; ISOTOPE LABELING; MALE; MULTIPLE SCLEROSIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RECEPTOR BINDING;

ADOLESCENT; ADULT; AGED; CORTICOTROPIN-RELEASING HORMONE; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMUS; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, GLUCOCORTICOID;

EID: 0032943389     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050349     Document Type: Article

References (47)

1. 1. Alexander I, Cass LJ, Enders M, Sarai K (1966) Adrenocortical response to high dosage ACTH therapy in patients with multiple sclerosis. Confin Neurol 28:1-17
2. 2. Armanini D, Endres S, Kuhnle U, Weber PC (1988) Parallel determination of mineralocorticoid and glucocorticoid receptors in T-and B-lymphocytes of human spleen. Acta Endocrinol 118: 479-482
3. 3. Besedovsky HO, del Rey A (1996) Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17: 64-102
4. 4. Birkmayer W, Iselstöger H, Seemann D (1955) Hormonstatus und Verlaufsform der Multiplen Sklerose. Klin Med 10:550-554
5. 5. Boyum A (1968) Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 21:97-107
6. 6. Brambilla F, Cazzullo CL, Smeraldi E, Zibetti A (1974) Endocrine function in multiple sclerosis: possible correlation with immunitary phenomena. Acta Neurol (Napoli) 29:618-625
7. 7. Brentani MM, Marchiori PE, Martins VR (1985) Glucocorticoid receptors of mononuclear leukocytes from myasthenia gravis patients. Acta Neurol Scand 72:188-192
8. 8. Erkut ZA, Hofman MA, Ravid R, Swaab DF (1995) Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis. J Neuroimmunol 62:27-33
9. 9. Fassbender K, Schmidt R, Mossner R, Kischka U, Kuhnen J, Schwartz A, Hennerici M (1998) Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol 55:66-72
10. 10. García-Reyes JA, Jenkins D, Forsham PH, Thorn GW (1952) Adrenocortical function in multiple sclerosis. Arch Neurol Psychiatry 68:776-782
11. 11. Giovannoni G, Hartung HP (1996) The immunopathogenesis of multiple sclerosis and Guillain-Barré syndrome. Curr Opin Neurol 9:165-177
12. 12. Grasser A, Möller A, Backmund H, Yassouridis A, Holsboer F (1996) Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Exp Clin Endocrinol Diabetes 104:31-37
13. 13. Harbuz MS, Rees RG, Eckland D, Jessop DS, Brewerton D, Lightman SL (1992) Paradoxical response of hypothalamic corticotrophin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRH-41 peptide and adenohypophyseal proopiomelanocortin mRNA during chronic inflammatory stress. Endocrinology 130:1394-1400
14. 14. Holboer F, Lauer CJ, Schreiber W, Krieg JC (1995) Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62:340-347
15. 15. Hughes PJ, Kirk PF, Compston DAS (1986) Suppressor T cells in family members of patients with multiple sclerosis. Brain 109:969-985
16. 16. Ketalear CJ, Delmotte P (1972) Results of adrenal and pituitary stimulation tests in patients with multiple sclerosis. Acta Neurol Scand 48:467-478
17. 17. Klapps P, Seyfert S, Fischer T, Scherbaum WA (1992) Endocrine function in multiple sclerosis. Acta Neurol Scand 85:353-357
18. 18. Kontula K, Myllyla G, Andersson LC (1981) Glucocorticoid receptors in human polymorphonuclear and mononuclear leucocytes. Concentrations and binding characteristics. Scand J Haematol 27:145-151
19. 19. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 33:1444-1452
20. 20. Linington C, Engelhardt B, Kapocs G, Lassmann H (1992) Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol 40:219-224
21. 21. Maida E, Summer K (1979) Serum cortisol levels of multiple sclerosis patients during ACTH treatment. J Neurol 220:143-148
22. 22. Martins VR, Birolli MI, Duarte AJ, Brentani MM (1987) Glucocorticoid receptors in subpopulations of human lymphocytes defined by monoclonal antibodies. Cell Immunol 105:443-446
23. 23. McPherson GA (1983) A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed 17:107-114
24. 24. Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, Gold PW (1994) Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol Metab 79:848-853
25. 25. Millac P, Cook DB, Chase K (1969) Endocrine function in multiple sclerosis. J Neurol Neurosurg Psychiatry 32: 414-418
26. 26. Modell S, Lauer CJ, Schreiber W, Huber J, Krieg JC, Holsboer F (1998) Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology 18:253-262
27. 27. Modell S, Yassouridis A, Huber J, Holsboer F (1997) Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 65:216-222
28. 28. Munson PJ, Rodbard D (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107: 220-239
29. 29. Paty DW, Kastrukoff L, Morgan N, Hiob L (1983) Suppressor T lymphocytes in multiple sclerosis; analysis of patients with acute relapsing and chronic progressive disease. Ann Neurol 14:445-449
30. 30. Piddlesden S, Lassmann H, Laffafin I, Morgan BP, Linington C (1991) Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation. Clin Exp Immunol 83:245-250
31. 31. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtelotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
32. 32. Purba JS, Raadsheer FC, Hofman MA, Ravid R, Polman CH, Kamphorst W, Swaab DF (1995) Increased number of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of patients with multiple sclerosis. Neuroendocrinology 62:62-70
33. 33. Reder AT, Lowy MT, Meltzer HY, Antel JP (1987) Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy. Neurology 37:849-853
34. 34. Reder AT, Makowiec RL, Lowy MT (1994) Adrenal size is increased in multiple sclerosis. Arch Neurol 51: 151-154
35. 35. Rupprecht R, Kornhuber J, Wodarz N (1990) Characterization of glucocorticoid binding capacity in human mononuclear leukocytes: Increase by metyrapone is prevented by dexamethasone pretreatment. J Neuroendocrinol 2:803-806
36. 36. Rupprecht R, Kornhuber J, Wodarz N, Lugauer J, Gobel C, Haack D, Beck G, Müller OA, Riederer P, Beckmann H (1991) Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone. Biol Psychiatry 29:1099-1109
37. 37. Schlaghecke R, Beuscher D, Kornely E, Specker C (1994) Effects of glucocorticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do not result in glucocorticoid resistance. Arthritis Rheum 37:1127-1131
38. 38. Schöbitz B, Reul JM, Holsboer F (1994) The role of the hypothalamic-pituitary-adrenocortical system during inflammatory conditions. Crit Rev Neurobiol 8:263-291
39. 39. Snyder BD, Lakatua DJ, Doe RP (1981) ACTH-induced cortisol production in multiple sclerosis. Ann Neurol 10:388-389
40. 40. Tanaka H, Akama H, Ichikawa Y, Homma M, Makino I (1992) Glucocorticoid receptor and inhibition of 3-O-methyl-D-glucose uptake by glucocorticoids in peripheral blood leukocytes from normal humans: correlation between receptor level and hormone effect in vitro. Acta Endocrinol (Copenh) 126:29-36
41. 41. Tanaka H, Ichikawa Y, Akama H, Homma M (1989) In vivo responsiveness to glucocorticoid correlated with glucocorticoid receptor content in peripheral blood leukocytes in normal humans. Acta Endocrinol (Copenh) 121:470-476
42. 42. Teasdale GM, Smith PA, Wilkinson R, Latner AL, Miller H (1967) Endocrine activity in multiple sclerosis. Lancet I: 64-68
43. 43. Von Bardeleben U, Holsboer F (1989) Cortisol response to a combined dexamethasone-human-corticotropin-releasing hormone challenge in patients with depression. J Neuroendocrinol 1: 485-488
44. 44. Wei T, Knight RA, Lightman SL (1997) Mitogenic response and steroid sensibility in MS lymphocytes. Acta Neurol Scand 96:28-33
45. 45. Wei T, Lightman SL (1997) The neuroendocrine axis in patients with multiple sclerosis. Brain 120:1067-1076
46. 46. Wender M, Gutowski J (1959) Zur Frage der Funktion der Nebennierenrinde bei der Multiplen Sklerose. Wien Klin Wochenschr 71:648-650
47. 47. Williams KC, Ulvestad E, Hickey WF (1994) Immunology of multiple sclerosis. Clin Neurosci 2:229-245